These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11060807)
1. Therapeutic potential of anti-inflammatory drugs in focal stroke. Barone FC; Parsons AA Expert Opin Investig Drugs; 2000 Oct; 9(10):2281-306. PubMed ID: 11060807 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Barone FC; Irving EA; Ray AM; Lee JC; Kassis S; Kumar S; Badger AM; Legos JJ; Erhardt JA; Ohlstein EH; Hunter AJ; Harrison DC; Philpott K; Smith BR; Adams JL; Parsons AA Med Res Rev; 2001 Mar; 21(2):129-45. PubMed ID: 11223862 [TBL] [Abstract][Full Text] [Related]
3. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. Barone FC; Irving EA; Ray AM; Lee JC; Kassis S; Kumar S; Badger AM; White RF; McVey MJ; Legos JJ; Erhardt JA; Nelson AH; Ohlstein EH; Hunter AJ; Ward K; Smith BR; Adams JL; Parsons AA J Pharmacol Exp Ther; 2001 Feb; 296(2):312-21. PubMed ID: 11160612 [TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in the neuropathology of stroke and neurotrauma. Feuerstein GZ; Wang X; Barone FC Neuroimmunomodulation; 1998; 5(3-4):143-59. PubMed ID: 9730680 [TBL] [Abstract][Full Text] [Related]
5. Inflammation as a therapeutic target in acute ischemic stroke treatment. Tuttolomondo A; Di Sciacca R; Di Raimondo D; Renda C; Pinto A; Licata G Curr Top Med Chem; 2009; 9(14):1240-60. PubMed ID: 19849665 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory mediators and stroke: new opportunities for novel therapeutics. Barone FC; Feuerstein GZ J Cereb Blood Flow Metab; 1999 Aug; 19(8):819-34. PubMed ID: 10458589 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Feuerstein GZ; Wang X; Barone FC Ann N Y Acad Sci; 1997 Oct; 825():179-93. PubMed ID: 9369986 [TBL] [Abstract][Full Text] [Related]
8. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes. Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164 [TBL] [Abstract][Full Text] [Related]
9. PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke. Guo Y; Chen X; Li D; Liu H; Ding Y; Han R; Shi Y; Ma X Clin Exp Immunol; 2018 Aug; 193(2):194-206. PubMed ID: 29603201 [TBL] [Abstract][Full Text] [Related]
10. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374 [TBL] [Abstract][Full Text] [Related]
11. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Kaminska B Biochim Biophys Acta; 2005 Dec; 1754(1-2):253-62. PubMed ID: 16198162 [TBL] [Abstract][Full Text] [Related]
12. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Legos JJ; Erhardt JA; White RF; Lenhard SC; Chandra S; Parsons AA; Tuma RF; Barone FC Brain Res; 2001 Feb; 892(1):70-7. PubMed ID: 11172750 [TBL] [Abstract][Full Text] [Related]
13. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Gao F; Yue TL; Shi DW; Christopher TA; Lopez BL; Ohlstein EH; Barone FC; Ma XL Cardiovasc Res; 2002 Feb; 53(2):414-22. PubMed ID: 11827692 [TBL] [Abstract][Full Text] [Related]
14. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344 [TBL] [Abstract][Full Text] [Related]
15. NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. Wei HH; Lu XC; Shear DA; Waghray A; Yao C; Tortella FC; Dave JR J Neuroinflammation; 2009 Aug; 6():19. PubMed ID: 19656406 [TBL] [Abstract][Full Text] [Related]
16. Luteolin Inhibits Fibrillary β-Amyloid Zhang JX; Xing JG; Wang LL; Jiang HL; Guo SL; Liu R Molecules; 2017 Feb; 22(3):. PubMed ID: 28245546 [TBL] [Abstract][Full Text] [Related]
17. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard. Yego EC; Dillman JF Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002 [TBL] [Abstract][Full Text] [Related]
18. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957 [TBL] [Abstract][Full Text] [Related]
19. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489 [TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Hedges JC; Singer CA; Gerthoffer WT Am J Respir Cell Mol Biol; 2000 Jul; 23(1):86-94. PubMed ID: 10873157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]